MBX Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- MBX Biosciences's estimated annual revenue is currently $4.6M per year.
- MBX Biosciences's estimated revenue per employee is $112,000
Employee Data
- MBX Biosciences has 41 Employees.
- MBX Biosciences grew their employee count by 71% last year.
MBX Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Clinical Development | Reveal Email/Phone |
2 | VP, CMC | Reveal Email/Phone |
3 | VP, Global Regulatory Affairs | Reveal Email/Phone |
4 | VP Pharmacology and Toxicology | Reveal Email/Phone |
5 | VP, Marketing | Reveal Email/Phone |
6 | VP, Clinical Development | Reveal Email/Phone |
7 | VP Marketing | Reveal Email/Phone |
8 | Director Regulatory Affairs | Reveal Email/Phone |
9 | Director Human Resources | Reveal Email/Phone |
10 | Director, Program Management | Reveal Email/Phone |
MBX Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $750M | 2704 | 0% | $14M | N/A |
#2 | $25.4M | 169 | 21% | $42M | N/A |
#3 | $13.9M | 99 | 22% | N/A | N/A |
#4 | $1.2M | 14 | 17% | N/A | N/A |
#5 | $39.6M | 263 | 6% | $49.3M | N/A |
#6 | $3.6M | 32 | 14% | N/A | N/A |
#7 | $13.3M | 95 | -10% | $42.4M | N/A |
#8 | $25.4M | 169 | 21% | $42M | N/A |
#9 | $498.5M | 2490 | 5% | $28.5M | N/A |
#10 | $2.3M | 23 | 5% | N/A | N/A |
What Is MBX Biosciences?
MBX Biosciences is a preclinical-stage biotech company committed to creating therapies to treat rare endocrine diseases where there is inadequate treatment available. MBX's leadership team has collaborated successfully over several decades to discover, develop and commercialize first-in-class endocrine therapeutics. A distinguishing strength of MBX is world-class proprietary peptide drug discovery.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$4.6M
Revenue (est)
71%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MBX Biosciences News
Carmel-based MBX Biosciences has hired Richard Bartram as chief financial officer. He most recently was chief financial officer at Esperion...
- Carmel-based biopharmaceutical company MBX Biosciences Inc. has named Richard Bartram chief financial officer. Bartram most recently served as...
MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPs). PEPs are...
Other Companies in Carmel
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.1M | 41 | -9% | N/A |
#2 | $6.9M | 41 | -52% | N/A |
#3 | $4.9M | 41 | 0% | N/A |
#4 | $6.9M | 41 | -5% | N/A |
#5 | $9.1M | 42 | -21% | N/A |